Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceplene and IL-2 for AML Remission Maintenance
NCT01347996Phase 4Completed
- Sponsor
- Cytovia Therapeutics
- Start
- Jul 2009
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
A Phase 4 trial of histamine dihydrochloride in acute myeloid leukemia (AML), sponsored by Cytovia Therapeutics. Started Jul 2009; status: completed.
02
Drugs
histamine dihydrochloride
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01347996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01347996.